Thursday, March 22, 2012

Will there be a drug bigger than Lipitor?

I see one drug, that might culminate into another Lipitor or Plavix, it is Januvia/Janumet. The drug is generating a staggering $4.5b in global sales in a very short span after launch. Even at this base, the Januvia franchise continues to grow in high double digits and takes just about 7 percent market share of the diabetes market. I expect the market share for the drug to atleast double from current levels in the next five years, which should make it the next Lipitor or even bigger than that.


No comments:

Post a Comment